baber/WOPTO huggingface dataset:
Patent ES-2526258-B2 (ES)
Title: Sistema autoeficiente de atado y desatado
Inventor: ROMERO ARAGÜETE FRANCISCO
IPC: B65B27/00
Filed: 2013-06-03
Granted: 2015-10-06
Abstract: Sistema autosuficiente de atado y desatado.#Consiste mediante una estructura metálica en el que participan dos tubos metálicos huecos (1), por ejemplo de 3 milímetros de diámetro y 5 centímetros de longitud, unidos el uno al otro por el largo de ambos y a la misma altura el uno del otro formando pues un paralelo de base estable y equilibrada por ambos tubos, en la parte final de salida de los alambres de los orificios de los tubos (1), éstos están separados el uno del otro, y virados en forma de tijera abierta con en un ángulo de 25 grados cada uno, para facilitar el estiramiento y frenado del alambre o material al salir de los tubos y facilitar su mejor torsión con atado más perfecto. En dichos tubos, en la parte, que es la frontal del sistema-herramienta, que es por la que se insertan los alambres o material, las paredes circulares de dichos tubos, tienen muescas (2) en las mismas paredes, con retirada de material y quedando pues perforadas las paredes en dichas posiciones, de 0,5 centímetros cuadrados aproximadamente de tamaño, a fin de provocar una torsión mejor el alambre o material. El interior de los tubos (1) es rugoso (3), igualmente para facilitar el estiramiento y frenado del alambre o material al salir de los tubos y facilitar su mejor torsión con atado más perfecto.#También, en la parte frontal de los tubos (1) y acoplado a éstos, se encuentra un garfio (4), (que puede instalarse y desinstalarse a voluntad), en forma cónica, de unos 5 centímetros de longitud total, y que está erguido en vertical a una posición de 90 grados enfrente de los orificios de entrada de los tubos (1), por donde entrará el alambre o material y a una distancia de los dichos tubos (1) de 4 centímetros.#La parte trasera de los tubos (1), por donde sale el alambre o material que previamente se ha introducido en la parte delantera de los tubos (1), los mismos están reducidos en su grosor de forma paulatina en su longitud formando unos embudos (5), pero permitiendo pasar el alambre o material hasta salir por los orificios de dichos embudos (5). Finalmente, unido a los tubos (1), y en la zona trasera donde se encuentran los embudos (5), se encuentra una varilla cilíndrica maciza que es el eje (6) para trasmitir la fuerza y movimiento por cualquier medio al sistema-herramienta, dicho eje (6) puede ser de 8 milímetros de grosor y 10 centímetros de longitud.#Se presenta igualmente, otro dibujo, exactamente igual, exceptuando el garfio (4), ya que como se ha indicado, puede instalarse o desinstalarse a voluntad, según la fortaleza del nudo o atado que quiera realizarse y el alambre o material que quiera utilizarse.
Patent AU-2001279722-B2 (AU)
Title: Sliding closure for casting molten metal and corresponding refractory plate unit
Inventor: BOCK RALF
IPC: B22D18/04
Filed: 2001-07-07
Granted: 2005-04-21
Abstract: In a slide valve closure for the casting of a metal melt a slider plate and a stationary closure part are braced against each other by means of spring units or by other means. There is provided a casing framework attachable to a mould or the like, in which is fixed a detachable casing part on which the spring units are held and in which the stationary closure part and the slider plate can be accommodated. This allows safe operation and simple and rapid mounting and dismounting of the slide valve closure.
Patent AU-2001289713-B2 (AU)
Title: Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof
Inventor: LORENZ BERND
IPC: C12N9/00
Filed: 2001-07-20
Granted: 2007-02-01
Abstract: Silicatein is an enzyme of silicate-forming organisms used for the synthesis of their silicate scaffold. The present invention relates to the use of highly-expressed and highly active recombinant silicatein, silicatein isolated from natural sources after gene induction as well as silicatein-fusion proteins for the synthesis of amorphous silicon dioxide (silicic acids and silicates), siloxanes as well as modification of these compounds and their technical use.
Patent AU-2001289847-B2 (AU)
Title: Aminopeptidase
Inventor: VISSER JACOB
IPC: A23C19/032
Filed: 2001-08-22
Granted: 2006-04-27
Abstract: The present invention describes isolated polypeptides from fungi which have aminopeptidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
Patent AU-2002214623-B2 (AU)
Title: Mechanism for the deployment of endovascular implants
Inventor: COX BRIAN J
IPC: A61F2/06
Filed: 2001-10-18
Granted: 2006-03-09
Abstract: A mechanism for the deployment of a filamentous endovascular device includes an elongate, flexible, hollow deployment tube having an open proximal end, and a coupling element attached to the proximal end of the endovawular device. The deployment tube includes a distal section terminating in an open distal end, with a lumen defined between the proximal and distal ends. A retention sleeve is fixed around the distal section and includes a distal extension extending a short distance past the distal end of the deployment tube. The emovascular device is attached to the distal end of the deployment robe during the manufacturing process by fixing the retention sleeve around the coupling element, so that the coupling element is releasably held within the distal extension of the deployment tube. In use, the deployment mbe, with the implant attached to its distal end, is passed though a microcatheter to a target vascular site until the endovascular device is deployed within the site. To detach the endovascular device from the deployment tube a biocompatible liquid is injected through the lumen of the deployment tube so as to apply pressure to the upstream side of the coupling element, which is thus pushed out of the retention sleeve by the fluid pressure, thereby detaching the endovascular device from the deployment tube. The coupling element may be a solid "plug" of polymeric material or metal, or it may be formed of a hydrophilic polymer that softens and becomes somewhat lubricious when contacted by the injected liquid. With the latter type of material, the hydration of the hydrophilic material results in physical changes that reduce the adhesion between the coupling element and the sleeve. Alternatively, the coupling element can be made principally of a non-hydrophilic material, with a hydrophilic coating.
Patent AU-2002249034-B2 (AU)
Title: Methods for treating the inflammatory component of a brain disorder
Inventor: MANDEL ARKADY
IPC: A61P25/08
Filed: 2002-04-08
Granted: 2007-08-02
Abstract: Disclosed are methods for treating and preventing neurological disorders which have a significant inflammatory component. The methods of the present invention involve extracting blood from a patient, subjecting the blood ex vivo to at least one stressor selected from the group consisting of an oxidative environment, thermal stress and UV light, and then re-administering the blood to the patient, thereby reducing inflammation.
Patent AU-2002366805-B2 (AU)
Title: Method and apparatus for manufacturing an endovascular graft section
Inventor: STEPHEN W PATRICK
IPC: A61F2/07
Filed: 2002-12-20
Granted: 2008-09-18
Abstract: A device and method for the manufacture of medical devices, specifically, endovascular grafts (16), or sections thereof. Layers of fusible material (13) are disposed upon a shape forming member (14) and seams (81) formed between the layers in a configuration that can produce inflatable channels (82) in desired portions of the graft. After creation of the seams (81), the fusible material of the inflatable channels may be fixed in a mold (90) to constrain an outer layer or layers of fusible material while the channels (82) are being expanded. A joint (330) may be produced on the endovascular graft by folding a flap (333) of a flexible material portion of an endovascular graft about a portion of an expandable member (314) to form a loop portion (348). The flap (333) may be secured in the loop configuration (348) so that tensile force on the expandable member (314) is transferred into a shear force on the fixed portion of the flap.
Patent AU-2003219797-B2 (AU)
Title: Automatic door and method of operating same
Inventor: FIELD GEORGE D
IPC: E05F15/20
Filed: 2003-02-19
Granted: 2008-04-03
Abstract: An automatic door and method of operating the same. The door includes a first processor which may be located proximate a leading movable edge of the door and a second processor which is remotely located from the first processor. The first and second processors are operably coupled with a bus configured to transmit digital signals therebetween. One or more input devices may be coupled with the first processor to indicate the status of an operational parameter of the door. Operational parameters are transmitted to the second processor, which controls a drive operably coupled with the door to control the position thereof in response to such operational parameters. The second processor is configured such that, upon breakdown of communication between the first and second processors, the second processor causes the door to enter into a predetermined status.
Patent AU-2003228632-B2 (AU)
Title: Damping mechanism
Inventor: SERKH ALEXANDER
IPC: F16H7/08
Filed: 2003-04-18
Granted: 2006-08-03
Abstract: An asymmetric damping mechanism for use in a belt tensioner. The damping mechanism comprises two parts having substantially similar arcuate shapes for engaging a tensioner. The first part is in contact with the second part at a pivotable point of contact. The point of contact position is determined according to the desired asymmetric damping factor. The first part is also in contact with a spring. The second part is in contact with a tensioner arm. The damping mechanism also comprises two damping shoes, each having a damping band. The damping band is joined to the damping shoe by a plurality of vertical grooves on the damping shoe cooperating with a plurality of grooves on the damping band. The damping mechanism has an asymmetric damping factor in the range of approximately 1.5 to 5.
Patent AU-2003237148-B2 (AU)
Title: Apparatus and method for processing chopped fiberglass bundles
Inventor: LEASE DANIEL T
IPC: B01F29/60
Filed: 2003-04-30
Granted: 2008-05-01
Abstract: A vibratory apparatus (10) and method for agglomerating chopped bundles of wet fiberglass strands into uniform segments includes a container (12) having a curved inner surface (14) disposed about a generally horizontal axis where the container (12) is mounted on a plurality of springs (20,22,24). The chopped bundles of wet fibreglass strands to be agglomerated are placed onto the curved inner surface at an input end of the container (12). A vibratory force is produced to cause the chopped bundles of wet fiberglass strands to be moved from the input end toward an output end of the container (12). The vibratory force causes the chopped bundles of wet fibreglass strands to be directed in a rising and falling path of rolling movement within the container (12). As a result of the rolling movement of the chopped bundles within the container (12) which is produced by the vibratory force, the copped bundles of wet fibreglass strands are converted into uniform segments by reason of agglomeration of the wet fiberglass strands.
Patent AU-2003251372-B2 (AU)
Title: Water treatment apparatus
Inventor: DONNELLY VERNON JAMES
IPC: B01D35/147
Filed: 2003-08-07
Granted: 2009-07-23
Abstract: A water treatment cartridge comprises a sealing surface arranged inwardly of its periphery, the sealing surface being formed, at least in part, by at least a portion of an inwardly facing, downwardly extending wall 52. The inwardly facing wall 52 may form the radially outer wall of an annular channel 50 extending around the top of the cartridge.
Patent AU-2003259624-B2 (AU)
Title: Drive-capable support or traction means and method for production thereof
Inventor: EICHHORN ROLAND
IPC: D07B1/14
Filed: 2003-10-31
Granted: 2008-05-01
Abstract: A drive-capable support or traction member and a method for the production thereof. The support or traction member has at least one layer of strands of synthetic fiber material and an outer casing encasing the strands. A lubricant is selectively incorporated in the support or traction member so that the strands are lubricated for movement relative to one another with a coefficient of friction.
Patent AU-2003265638-B2 (AU)
Title: Methods and apparatus for a variable resistor configured to compensate for non-linearities in a heating element circuit
Inventor: RINALDIS DAVID
IPC: H05B3/00
Filed: 2003-08-26
Granted: 2007-01-04
Abstract: An improved variable resistor at least partially compensates for non-linearities in an electrical circuit containing a heating element, for example, a thin-film heating element. A controllable heater includes a heating element, a voltage source (for example, a standard AC electrical outlet) coupled to the heating element, and a variable resistor coupled to the heating element and voltage source. The variable resistor includes a fixed resistive element (for example, one or more thin-film resistors) and a moveable element such as a slider control. The moveable element adjustably contacts the fixed resistive element at a contact point associated with the position such that the variable resistor has a resistance that is at least partially non-linearly related to the position, but wherein the heating element has a dissipated power that is at least partially linearly related to the position of the variable resistor. Such a system may be used in conjunction with a vapor-delivery device to provide more linear control over the intensity of fragrance provided within an environment.
Patent AU-2003291994-B2 (AU)
Title: Frozen confection
Inventor: GHAFFARI RAMIN
IPC: A23L33/20
Filed: 2003-11-03
Granted: 2007-08-02
Abstract: Frozen confections having a combination of ingredients which permit the formulator to continue to provide outstanding organoleptic properties while at the same time reducing the caloric impact for those consumers who desire to limit their caloric intake. In a first aspect, the invention relates to a frozen confection which comprises less than 5 wt. % triglyceride fat, polydextrose and tricalcium phosphate. In another aspect, the product includes both polydextrose and cream, optionally in combination with tricalcium phosphate and/or karaya gum to produce a low fat frozen confection with good organoleptic properties. In a further aspect, the invention comprises a frozen confection comprising: less than 5 wt. % triglyceride fat, polydextrose, and a karaya gum. The products of the invention combine good organoleptic properties with a substantially reduced fat level compared to regular fat and, especially premium and super-premium ice creams. Preferably, the confection employs a level of triglyceride fat which is less than 1 wt. %, more preferably less than 0.5 wt. %.
Patent AU-2004267372-B2 (AU)
Title: Fuel for jet, gas turbine, rocket, and diesel engines
Inventor: CONNOR DANIEL STEDMAN
IPC: C10L1/16
Filed: 2004-07-22
Granted: 2008-03-13
Abstract: A fuel or fuel blendstock for jet, gas turbine, rocket, and diesel engines, particularly jet, rocket, and diesel engines that utilizes components of conventional petroleum not currently utilized for jet, gas turbine, rocket, and diesel fuels, such as benzene, linear, and lightly branched alkanes, that may be alkylated with aromatic moieties to make monoaromatics for use in jet and diesel fuels. Additionally, a fuel having such monoaromatics having multiple desired properties such as higher flash point, low pour point, increased density, better lubricity, aerobic degradability, reduction in toxicity, and additionally can deliver benefits in blendstocks.
Patent AU-2004289821-B2 (AU)
Title: Adenocarcinoma specific antibody SAM-6, and uses thereof
Inventor: HANS-KONRAD MULLER-HERMELINK
IPC: C07K16/30
Filed: 2004-11-12
Granted: 2011-10-06
Abstract: The present invention features a polypeptide, such as an antibody produced by the hybridoma SAM-6 and its use in the treatment and diagnosis of neoplasms.
Patent AU-2004292370-B2 (AU)
Title: Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof
Inventor: MEYRUEIX REMI
IPC: A61K38/21
Filed: 2004-11-19
Granted: 2010-12-02
Abstract: A liquid pharmaceutical formulation (I) for prolonged release of interferon(s) (IFN) comprises a low viscosity aqueous colloidal suspension of submicron particles of water-soluble, biodegradable polymers (II) carrying hydrophobic groups, non-covalently associated with IFN(s) and optionally other active agent(s), where on parenteral injection (I) forms a gelled depot for prolonging the duration of active agent release to more than 24 hours. A liquid pharmaceutical formulation (I) for prolonged release of interferon(s) (IFN) comprises a low viscosity aqueous colloidal suspension (with water as dispersion medium) based on submicron particles (SMP's) of water-soluble, biodegradable polymers (II) carrying hydrophobic groups (HG's), non-covalently associated with IFN(s) and optionally other active agent(s). On parenteral injection, (I) forms a gelled depot in vivo (at least partially due to physiological proteins), controlling and prolonging the duration of active agent release to more than 24 hours. (I) is liquid under the injection conditions; at physiological temperature and/or pH; and/or in presence of physiological electrolytes at physiological concentrations and/or surfactant(s). Independent claims are included for: (1) a variant of (I) as described above, where the duration of release of active agents is not restricted but the concentration of (II) is sufficiently high to form a gelled depot in vivo in presence of protein(s) after parenteral injection; (2) novel derived products (preferably in powder or gel form), consisting of SMP's formed by non-covalent association of (II) and active agents as above and obtained from (I); and (3) methods of preparation of (I). ACTIVITY : Virucide; immunomodulator; cytostatic. MECHANISM OF ACTION : None given in the source material.
Patent AU-2004316388-B2 (AU)
Title: Shoulder prosthesis with humeral fracture stem
Inventor: FLURIN PIERRE-HENRI
IPC: A61F2/30
Filed: 2004-09-29
Granted: 2011-01-06
Abstract: Various embodiments of the present invention are directed to a shoulder prosthesis. These embodiments may relate to a shoulder prosthesis including, for example, a humeral stem for fracture indication. Of note, certain embodiments of the present invention provide a humeral prosthesis with improved integration of the tuberosities around the humeral stem. Various methods relating to uses and applications of the prosthesis are also disclosed.
Patent AU-2005215663-B2 (AU)
Title: Support cradle for rolled coils and other cylindrical objects
Inventor: DEMENT R BRUCE
IPC: B65H75/18
Filed: 2005-09-27
Granted: 2009-03-19
Abstract: A cradle unit (10) for supporting metal coils, and other cylindrical objects, consists of two, parallel and separate saddles (12,14) made of polyurethane having a hardness range of between 50 Shore A and 90 Shore D, which saddles are connected together via a pair of parallel steel angle-brackets (30,32) that provide inherent structural integrity to the cradle unit itself, while still allowing the unit to conform to the shape or level of the underlying support structure. The single cradle unit may be as a mobile support-device, or may be bolted or otherwise attached to a surface for a specific location of the stored product. The cradle unit of the invention may, also, be attached to the bed of a transportation vehicle, such as a truck trailer or rail car, in order to provide secure, protective storage and location of the items. In this case, the nature of the resilient or soft material from which the cradle unit is made provides shock-absorption qualities for the transported coil. The cradle unit is generally concave-shaped and has a first main or central lower concave curvature (16',18') of a first radius, and a middle or secondary transitional curvature (20,22) that connects the first main lower curvature to an upper, tertiary concave curvature (16'',18'') of a second radius greater than the first radius, so that coils or rolls of different diameter may be safely and firmly supported.
Patent AU-2005266201-B2 (AU)
Title: Catheter, apparatus for creating a linear ablation and a method of ablating tissue
Inventor: HAYWOOD GUY
IPC: A61B18/02
Filed: 2005-07-25
Granted: 2012-01-19
Abstract: A catheter is provided with an anchoring member for anchoring a part of a linear ablating head of the catheter to a structure. The structure can be a cryogenically anchored point catheter. This allows the surgeon to position the linear catheter more exactly in the heart chamber and overcomes the adverse effects of the slippery and irregular heart chamber walls.
Patent AU-2006200687-B2 (AU)
Title: System and method for monitoring a validator
Inventor: TOOHEY TONY
IPC: A63F5/04
Filed: 2006-02-20
Granted: 2012-04-19
Abstract: -32 A system for monitoring a validator that assesses a token is disclosed. The system includes an input device 4 for receiving messages 5 from a machine 2 including a validator 6. The messages containing data indicative of validator events such as an assessment of a token resulting in 5 acceptance of the token and an assessment of a token resulting in rejection of the token. The system further includes a processor 7 for deriving timing information for the validator events and for comparing the data and timing information with predetermined criteria. Personnel alerts are raised when predetermined criteria are satisfied, and maintenance of validators may be scheduled in dependence upon criteria related to assessments of tokens resulting in rejection. 10 [Figure 2) (Z
Patent AU-2006203622-B2 (AU)
Title: Inflammation-inhibiting compounds
Inventor: LUGER THOMAS
IPC: C07K5/09
Filed: 2006-08-22
Granted: 2007-08-09
Abstract: Use of lysine derivatives (I), or their acceptable salts for treatment and/or prevention of inflammatory diseases. Use of lysine derivatives of formula (I), or their acceptable salts, for treatment and/or prevention of inflammatory diseases. X : hydroxy, amino, alkoxy, Pro or Pro-Thr (I) may be N-acylated and/or C-amidated or -esterified. An independent claim is also included for in vitro preparation of cells that can impart tolerance to an antigen (Ag) by treating antigen-presenting cells (APC) with alpha-melanocyte stimulating hormone (aMSH), or its biologically active fragments or derivatives, and with Ag, in either order or simultaneously. [Image] ACTIVITY : Antiinflammatory; Antiallergic; Immunosuppressive; Antifibrotic; Dermatological; Antipsoriatic; Antiasthmatic; Antiulcer. Mice were sensitized to the hapten DNFB, then (after 7 days) the same hapten was applied to the ear, and after a further 24 hr the swelling of the ear was measured. The mean value was 7 (mmX10 -2>), but only 1 when the mice had been injected, intraperitoneally, with an unspecified dose of Lys-Pro-Thr, 2 hr before sensitization. The treated animals did not respond to a second sensitization/challenge, showing that tolerance had been induced. MECHANISM OF ACTION : (I) inhibits activation of the NF-kappaB transcription factor by cytokines or lipopolysaccharide; Reduces expression of costimulatory molecules from dendritic cells and increases production of interleukin-10 from monocytes. (I) may bind to the beta -adrenergic and type 1 interleukin-1 receptors, possibly also to other receptors.